Trading Tech Stocks; Tech Stock News and daily Podcasts

Monday, July 22, 2019

The #AIEye: Microsoft (Nasdaq: $MSFT) Partners with OpenAI, Amazon (Nasdaq: $AMZN) Announces Two New #Robotics Fulfillment Centres and CEVA (Nasdaq: $CEVA) Acquires Hillcrest Labs

The #AIEye: Microsoft (Nasdaq: $MSFT) Partners with OpenAI, Amazon (Nasdaq: $AMZN) Announces Two New #Robotics Fulfillment Centres and CEVA (Nasdaq: $CEVA) Acquires Hillcrest Labs

Global Conversational #AI Market to See 32.4% CAGR from 2019-2025

Point Roberts WA, Vancouver BC – July 22, 2019 – Investorideas.com (www.investorideas.com), a global investor news source covering Artificial Intelligence (AI) brings you today’s edition of The AI Eye- watching stock news, deal tracker and advancements in artificial intelligence.

Listen to today’s podcast:

https://www.investorideas.com/Audio/Podcasts/2019/072219-AI-Eye.mp3

Read this in full at https://www.investorideas.com/news/2019/artificial-intelligence/07221AIEye-MSFT-AMZN-CEVA.asp

Hear the Ai Eye on Spotify

Today’s Column- The AI Eye- Watching stock news, deal tracker and advancements in artificial intelligence

Stocks discussed: (NasdaqGS:MSFT) (NasdaqGS:AMZN) (NasdaqGS:CEVA) (NasdaqGS:IDCC)

Microsoft (NasdaqGS:MSFT) and OpenAI have partnered to extend the former’s Azure capabilities in large-scale AI systems. As part of the agreement, the two companies will work to build new Azure AI supercomputing technologies and create an artificial general intelligence (AGI). Satya Nadella , CEO, Microsoft, commented:

"AI is one of the most transformative technologies of our time and has the potential to help solve many of our world's most pressing challenges. By bringing together OpenAI's breakthrough technology with new Azure AI supercomputing technologies, our ambition is to democratize AI — while always keeping AI safety front and center — so everyone can benefit."

Amazon (NasdaqGS:AMZN) has announced plans to open two new robotics fulfillment centres in Ohio. According to the official website, “Amazon Robotics automates fulfilment center operations using various methods of robotic technology including autonomous mobile robots, sophisticated control software, language perception, power management, computer vision, depth sensing, machine learning, object recognition, and semantic understanding of commands”. Alicia Boler Davis, Amazon’s Vice President of Global Customer Fulfillment, said:

“Ohio has been a great place to do business, serve customers and create jobs; as a result, we are thrilled to develop two state-of-the-art fulfillment centers in Akron and Rossford. We're excited to grow our team in the Buckeye state, which now includes more than 8,500 Amazonians, and be part of the larger Ohio community.”

CEVA, Inc. (NasdaqGS:CEVA) has acquired Hillcrest Laboratories, Inc. from InterDigital, Inc. (NasdaqGS:IDCC). Hillcrest Labs is a leading global supplier of software and components for sensor processing in consumer and IoT devices. Gideon Wertheizer, CEO of CEVA, commented:

"We are truly excited to welcome the Hillcrest Labs team to CEVA. Their unrivalled expertise in sensor processing and innovative sensor fusion technology, as well as proven track record of high-volume shipments align perfectly with our diversification strategy in the smart sensing domain. This acquisition presents opportunities for multiple royalty growth vectors, including from OEMs, and enables us to be a pioneer in the emerging fields of AR & VR and the different classes of robots. Together with our broad portfolio of connectivity, sound, vision and AI technologies, Hillcrest labs will enable us to continue to redefine the limits of our technology solutions for the data-driven world."

Global Conversational AI Market to See 32.4% CAGR from 2019-2025

A report from Research and Markets finds that the global conversational AI market will see a compound annual growth rate (CAGR) of 32.4 percent in the forecast period 2019-2025. An excerpt from the report description reads:

The market for conversational AI platform is driven by the increasing number of messaging apps and voice assistants. Several industries are investing in conversational chatbots and are integrating AI-based chatbots with websites to stay ahead of the competition, as customers prefer chatting as the primary mode of communication. Preference to deal with human and data privacy & security concerns are hampering the market growth.

The implementation of conversational AI is anticipated to grow further as more and more companies are integrating conversational AI platforms in the existing chat, contact, and call centers for offering seamless interactivity and delivering personalized interactions to improve customer engagement.

Sam Mowers, Investorideas.com

Read and hear other editions of the AI Eye

For a list of artificial intelligence stocks on Investorideas.com visit here or become an Investor Ideas member

About Investorideas.com - News that Inspires Big Investing Ideas Investorideas.com is a recognized news source publishing third party news and press releases plus we create original financial content. Learn about investing in stocks and sector trends from Investorideas.com with our news alerts , articles , podcasts and videos talking about cannabis, crypto, technology including AI and IoT , mining ,sports biotech, water, renewable energy and more . Investorideas.com original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and stock news column, Investor Ideas #Potcasts #Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change Podcast and the AI Eye Podcast and column covering developments in AI.

The Investorideas.com podcasts are also available on iTunes, Spotify, Tunein, Stitcher, Spreaker.com, iHeartRadio and Google Play Music.

Visit the Podcast page at Investorideas.com:

https://www.investorideas.com/Audio/

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.

More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

The AI Eye- Watching stock news, deal tracker and advancements in artificial intelligence is an original content brand of Investorideas.com

Contact Investorideas.com

800 665 0411

Get more tech stocks investor ideas- news, articles, podcasts and stock directories

Friday, July 19, 2019

The #AIEye: BMW Joins Tencent (OTC: $TCEHY) to Launch Computing Centre in China for Self-Driving Cars and VMware (NYSE: $VMW) Acquires Startup Bitfusion

The #AIEye: BMW Joins Tencent (OTC: $TCEHY) to Launch Computing Centre in China for Self-Driving Cars and VMware (NYSE: $VMW) Acquires Startup Bitfusion

Global Automotive #AI Market to Reach $5.827 Billion by 2024

Point Roberts WA , Vancouver BC – July 19, 2019 – Investorideas.com (www.investorideas.com), a global investor news source covering Artificial Intelligence (AI) brings you today’s edition of The AI Eye- watching stock news, deal tracker and advancements in artificial intelligence.

Listen to today’s podcast:

https://www.investorideas.com/Audio/Podcasts/2019/071919-AI-Eye.mp3

Read this in full at https://www.investorideas.com/news/2019/artificial-intelligence/07191AIEye-BMW-TCEHY-China-VMW-Bitfusion.asp

Hear the Ai Eye on Spotify

Today’s Column- The AI Eye- Watching stock news, deal tracker and advancements in artificial intelligence

Stocks discussed: (OTC:TCEHY) (NYSE:VMW)

BMW (XETRA:BMW.DE) is joining with Tencent Holdings (OTC:TCEHY) to launch a computing centre in China for self-driving cars. The facility will begin operating later this year, with BMW aiming to introduce semi-autonomous cars to China in 2021. The computing centre, which may be built near the city of Tianjin, “will provide cars with data-crunching capabilities to help them drive semi-autonomously and, eventually, autonomously”. Jochen Goller, head of BMW’s China operations, said in a statement that the facility:

“…will support BMW’s autonomous driving development and innovation in China. BMW can, therefore, develop autonomous driving solutions that fit better with the specific driving conditions in China.”

VMware, Inc. (NYSE:VMW) has acquired startup Bitfusion – “a pioneer in virtualization of accelerated compute with a strong focus on GPU technology” – according to a company blog post. Krish Prasad, Senior Vice President and General Manager, Cloud Platform Business Unit, VMware, commented:

Once closed, the acquisition of Bitfusion will bolster VMware’s strategy of supporting AI- and ML-based workloads by virtualizing hardware accelerators. Multi-vendor hardware accelerators and the ecosystem around them are key components for delivering modern applications. These accelerators can be used regardless of location in the environment – on-premises and/or in the cloud.

Global Automotive AI Market to Reach $5.827 Billion by 2024

A report from Big Market Research finds that the global automotive AI market will grow from $445.8 million USD in 2017 to $5.827 billion USD in 2024 with a compound annual growth rate (CAGR) of 43.8 percent in the forecast period 2018-2024, according to coverage from Innovative Reports. Excerpts outlining the market read:

Artificial intelligence has been increasingly adopted by the automotive industry, which is among the major industries using AI to mimic the action of humans. Applications that incorporate AI systems in automotive are semiautonomous and autonomous vehicles. In autonomous vehicles, AI collects, processes, and chooses the specific action based on the information gathered. Semiautonomous and autonomous vehicles use several advanced tools such as long-range radar, LIDAR, cameras, short/medium radar, and ultrasound to gather information and understand the world around them. After collection of data through different tools, AI analyzes the situation through its technologies such as machine & deep learning, natural language processing, and computer vision. Artificial intelligence has several applications for these vehicles such as, incorporates speech recognition for advanced communication with passengers, directs vehicles towards refueling station or recharge station when it is running low on fuel and analyzes less populated and congested roads among others.

The growth of the automotive artificial intelligence market is driven by rise in demand for autonomous vehicles and increase in preference for enhanced user experience & convenience features. However, the threat of hackers and rise in cybercrime are expected to restrain the market growth. On the contrary, rise in demand for the premium vehicle segment is anticipated to provide lucrative growth opportunities for the market.

Sam Mowers, Investorideas.com

Read and hear other editions of the AI Eye

For a list of artificial intelligence stocks on Investorideas.com visit here or become an Investor Ideas member

The Investorideas.com podcasts are also available on iTunes, Spotify, Tunein, Stitcher, Spreaker.com, iHeartRadio and Google Play Music.

Visit the Podcast page at Investorideas.com:

https://www.investorideas.com/Audio/

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

The AI Eye- Watching stock news, deal tracker and advancements in artificial intelligence is an original content brand of Investorideas.com

Contact Investorideas.com

800 665 0411

Get more tech stocks investor ideas- news, articles, podcasts and stock directories

Investor Ideas Adds Recent IPO’s in #Biotech (NASDAQ: $PSNL) (NASDAQ: $STOK), #Tech (NASDAQ: $SONM) and #Defense (NYSE: $PSN)

Investor Ideas Adds Recent IPO’s in #Biotech

(NASDAQ: $PSNL) (NASDAQ: $STOK), #Tech (NASDAQ: $SONM) and #Defense (NYSE: $PSN)

Point Roberts WA, Delta BC, July 19, 2019 – (Investorideas.com Newswire) Investorideas.com, a global news source and leading investor resource announces this week’s additions to its global stock directories in biotech, tech and defense.

Read this in full at https://www.investorideas.com/news/2019/main/07191Stocks.asp

This week’s new additions are all recent Nasdaq IPO’s with the majority in the biotech sector.

New biotech companies include biopharma firms, life sciences companies and drug development companies working on treatments for cancer, diabetes, heart disease, genetic disorders, neurologic disorders and others.

The latest tech companies include a Russian online job recruitment platform and a company designing ultra-rugged mobility solutions.

The newest defense stock, PARSONS CORP. (NYSE:PSN) is a leading provider of tech solutions focused on the defense, intelligence and critical infrastructure markets and is also involved in cyber security solutions, thus crossing over onto the tech sector stock list as well.

New Biotech Companies:

PERSONALIS, INC. (NasdaqGM:PSNL) is a growing cancer genomics company transforming the development of next-generation therapies by providing more comprehensive molecular data about each patient’s cancer and immune response. The company’s NeXT™ Platform is designed to adapt to the complex and evolving understanding of cancer, providing its biopharmaceutical customers with information on all of the approximately 20,000 human genes, together with the immune system, from a single tissue sample. The Personalis Clinical Laboratory is GxP aligned as well as CLIA’88-certified and CAP-accredited.

STOKE THERAPEUTICS, INC. (NasdaqGS:STOK) is a biotechnology company that is pioneering a new way to treat the underlying causes of severe genetic diseases by precisely upregulating protein expression to restore target proteins to near normal levels. Stoke aims to develop the first precision medicine platform to target the underlying cause of a broad spectrum of genetic diseases in which the patient has one healthy copy of a gene and one mutated copy that fails to produce a protein essential to health. These diseases, in which loss of approximately 50 percent of normal protein expression causes disease, are called autosomal dominant haploinsufficiencies. Stoke was launched with investments by Apple Tree Partners. Stoke is headquartered in Bedford, Massachusetts with offices in Cambridge, Massachusetts.

APPLIED THERAPEUTICS INC. (NasdaqGM:APLT) is a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need. The company’s lead drug candidate, AT-001, is a novel aldose reductase inhibitor (ARI) that is being developed for the treatment of Diabetic Cardiomyopathy, or DbCM, a fatal fibrosis of the heart. The company plans to initiate a Phase 2/3 pivotal study in DbCM in 2019. Applied Therapeutics is also developing AT-007, a central nervous system penetrant ARI, for the treatment of Galactosemia, a rare pediatric metabolic disease, and initiated a Phase 1/2 clinical trial in June 2019. The preclinical pipeline also includes AT-003, an ARI designed to cross through the back of the eye when dosed orally, for the treatment of diabetic retinopathy, expected to advance into a Phase 1 study in 2020.

MILESTONE PHARMACEUTICALS INC. (NasdaqGS:MIST) headquartered in Montreal, Canada with a U.S. subsidiary in Charlotte, N.C., is a Phase 3 clinical-stage biopharmaceutical company dedicated to developing and commercializing the investigational new drug etripamil for the treatment of cardiovascular indications. Etripamil is a novel, potent and short-acting calcium channel blocker designed by Milestone and being developed as a rapid-onset nasal spray to be administered by the patient to terminate episodes of paroxysmal supraventricular tachycardia (PSVT) as they occur.

NEXTCURE, INC. (NasdaqGS:NXTC) is a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases. Through our proprietary FIND-IO™ platform, we study various immune cells to discover and understand targets and structural components of immune cells and their functional impact in order to develop immunomedicines. Our initial focus is to bring hope and new treatments to patients who do not respond to current cancer therapies, patients whose cancer progresses despite treatment and patients with cancer types not adequately addressed by available therapies.

AXCELLA HEALTH INC. (NasdaqGM:AXLA) is designing and developing AXA Candidates, compositions of endogenous metabolic modulators, or EMMs, engineered in distinct ratios, designed to target and maximize the fundamental role that EMMs play in regulating multiple metabolic functions. Axcella’s AXA Candidates are generated from its proprietary, human-focused AXA Development Platform. Axcella believes its expertise and capabilities in EMMs position it to become a preeminent biotechnology company reprogramming metabolism to address a diverse set of complex diseases and support health. Axcella’s AXA Development Platform has already produced a pipeline of product candidates in programs targeting liver, muscle and blood. Axcella was founded by Flagship Pioneering.

CORTEXYME, INC. (NasdaqGS:CRTX) is a clinical stage biopharmaceutical company pioneering a novel disease-modifying therapeutic approach to treat a key underlying cause of Alzheimer’s disease and other degenerative diseases. Cortexyme is targeting a specific, infectious pathogen found in the brain of Alzheimer’s patients and tied to neurodegeneration and neuroinflammation in animal models. The company’s lead investigational medicine, COR388, is the subject of the GAIN trial, an ongoing Phase 2/3 clinical study in patients with mild to moderate Alzheimer’s disease.

TREVI THERAPEUTICS, INC. (NasdaqGM:TRVI) is a clinical-stage biopharmaceutical company focused on the development and commercialization of nalbuphine ER to treat serious neurologically mediated conditions. Trevi is currently developing nalbuphine ER for the treatment of chronic pruritus, chronic cough in patients with idiopathic pulmonary fibrosis (IPF) and levodopa-induced dyskinesia (LID) in patients with Parkinson’s disease. These conditions share a common pathophysiology that is mediated through opioid receptors in the central and peripheral nervous systems. Trevi is currently conducting a Phase 2b/3 clinical trial of nalbuphine ER, referred to as the PRISM trial, in patients with severe pruritus associated with prurigo nodularis.

AVANTOR, INC. (NYSE:AVTR) is a leading global provider of mission critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. We operate in more than 30 countries and deliver an extensive portfolio of products and services. We set science in motion to create a better world.

TRANSMEDICS GROUP, INC. (NasdaqGM:TMDX) is the world’s leader in portable ex-vivo warm perfusion and assessment of donor organs for transplantation. Headquartered in Andover, Massachusetts, the company was founded to address the unmet need for more and better organs for transplantation and has developed technologies to preserve organ quality, assess organ viability prior to transplant, and potentially increase the utilization of donor organs for the treatment of end-stage heart, lung and liver failure.

New Tech Companies:

HEADHUNTER GROUP PLC (NasdaqGS:HHR) is the leading online recruitment platform in Russia and CIS focusing on facilitating the recruitment process and connecting millions of job seekers with hundreds of thousands of employers annually. HeadHunter is one of the most visited job and employment website globally, our CV database contains 36.2 million CVs and our platform hosts a daily average of more than 559,000 job postings.

SONIM TECHNOLOGIES INC (NasdaqGM:SONM) s a leading U.S. provider of ultra-rugged mobility solutions designed specifically for task workers physically engaged in their work environments, often in mission-critical roles. The Sonim solution includes ultra-rugged mobile phones, a suite of industrial-grade accessories, and data and workflow applications which are collectively designed to increase worker productivity, communication and safety on the job site.

New Defense Companies:

PARSONS CORP. (NYSE:PSN) is a leading provider of technology-driven solutions focused on the defense, intelligence, and critical infrastructure markets. Celebrating 75 years of operations, Parsons provides technical design and engineering services and software products to address our customers' challenges. Parsons has differentiated capabilities in cybersecurity, intelligence, missile defense, space, connected communities, physical infrastructure, and mobility solutions. Parsons' combination of talented professionals and advanced technology enables a safer, smarter, and more interconnected world.

The directories are not meant as recommendations but as a research tool to discover opportunities and trading ideas in a particular sector.

About Investorideas.com - News that Inspires Big Investing Ideas

Investorideas.com is a recognized news source publishing third party news and press releases plus we create original financial content. Learn about investing in stocks and sector trends from Investorideas.com with our news alerts , articles , podcasts and videos talking about cannabis, crypto, technology including AI and IoT , mining ,sports biotech, water, renewable energy and more . Investorideas.com original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and stock news column, Investor Ideas #Potcasts #Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change Podcast and the AI Eye Podcast and column covering developments in AI.

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Learn more about our news, PR and social media services at Investorideas.com

https://www.investorideas.com/Investors/Services.asp

To sponsor a daily podcast for the month or to be an expert guest please contact us!

Contact Investorideas.com

800-665-0411

AI News: VSBLTY (CSE: $VSBY.C) (OTC: $VSBGF) Announces Closing of Convertible Debenture Offering

AI News: VSBLTY (CSE: $VSBY.C) (OTC: $VSBGF) Announces Closing of Convertible Debenture Offering

THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES FOR DISSEMINATION IN THE UNITED STATES

Philadelphia, PA - July 19, 2019 (Investorideas.com Newswire) VSBLTY Groupe Technologies Corp. (CSE: VSBY) (5VS.F) (VSBGF) ("VSBLTY" or the "Company") is pleased to announce that it has closed a non-brokered private placement offering of convertible debenture ("Debentures") for gross proceeds of CAD $745,500 (the "Offering").

Read this in full at https://www.investorideas.com/CO/VSBY/news/2019/07191ConvertibleDebenture.asp

The Debentures bear interest at 10% per annum on an accrual basis, calculated and payable semi-annually, maturing on July 18, 2021 (the "Maturity Date") that is 24 months from the date of issuance on July 18, 2019 (the "Closing Date").

The Debentures, together with any interest accrued but unpaid, may be convertible, in whole or in part, at any time before the Maturity Date, into units of the Company (each, a "Unit") at $0.45 per Unit, if converted at any time before one year from the Closing Date, or otherwise convertible at $0.60 per Unit if converted after one year from the Closing Date but before the Maturity Date.

Each Unit consists of one common share in the capital of the Company (a "Share") and one-half of a Share purchase warrant (each whole warrant, a "Warrant"). Each Warrant will be exercisable into one Share (each a, "Warrant Share") at a price of $0.60 per Warrant Share for a period of 24 months from the Closing Date, subject to acceleration. The Company may exercise its warrant acceleration right, if on any ten consecutive trading days, beginning on the date that is four months and one day following the Closing Date, the closing price of the Company's Shares on the CSE is greater than $1.00 per Share. If the Company exercises its warrant acceleration right, the new expiry date of the Warrants will be the 30th day following the notice of such exercise.

The net proceeds from the Offering will be used for acquisitions and general and corporate working capital purposes.

The Debentures are subject to a statutory four month and one day hold period, which expires on November 19, 2019.

Guy Lombardo, a director of the Company, and Jay Hutton, the CEO and a director of the Company, purchased Debentures in the principal amounts of $327,500 and $25,000, respectively, under the Offering. These purchases each constituted a "related party transaction" within the meaning of Multilateral Instrument 61-101 - Protection of Minority Security Holders in Special Transactions ("MI 61-101"). These issuances to insiders are exempt from the formal valuation and the minority shareholder approval requirements of MI 61-101 as the fair market value of the Debentures issued to or the consideration paid by such person did not exceed 25% of the Company's market capitalization.

In accordance with the terms of a merger agreement dated December 12, 2018 between the Company, VSBLTY Merger Co. and VSBLTY Inc., common shares in the capital of VSBLTY issued to former VSBLTY, Inc. shareholders and former holders of VSBLTY, Inc. debentures are subject to voluntary hold periods. The Company has received commitments from approximately 82% of such shareholders to extend the voluntary hold periods for a period of three months.

The Company is not proceeding with the unit offering it previously announced on May 8, 2019.

The securities referred to in this news release have not been, nor will they be, registered under the United States Securities Act of 1933, as amended, and may not be offered or sold within the United States or to, or for the account or benefit of, U.S. persons absent U.S. registration or an applicable exemption from the U.S. registration requirements. This release does not constitute an offer for sale of, nor a solicitation for offers to buy, any securities in the United States. Any public offering of securities in the United States must be made by means of a prospectus containing detailed information about the issuer and its management, as well as financial statements.

On Behalf of the Board of VSBLTY Groupe Technologies Inc.

"Jay Hutton"

CEO & Director

Investor Relations
MarketSmart Communications Inc., +1 877 261-4466
info@marketsmart.ca

CONTACT: Linda Rosanio, 609-472-0877
lrosanio@vsblty.net

About VSBLTY (www.vsblty.net)

Headquartered in Philadelphia, VSBLTY (CSE: VSBY) (Frankfurt: 5VS) (OTCBB:VSBGF) is the world leader in Proactive Digital Display™, which transforms retail and public spaces as well as place-based media networks with SaaS-based audience measurement and security software that uses artificial intelligence and machine learning.

The CSE does not accept responsibility for the adequacy or accuracy of this release.

FORWARD LOOKING STATEMENT

This news release contains forward-looking statements, including statements regarding the attributes of the securities to be offered and sold by the Company, the proposed use of the net proceeds of the Offering, the closing date of the Offering and the future price of the Shares on the Canadian Securities Exchange, and other statements that are not historical facts. Forward-looking statements are often identified by terms such as "will", "may", "should", "anticipate", "expects" and similar expressions. All statements other than statements of historical fact included in this release are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements.

The reader is cautioned that assumptions used in the preparation of any forward-looking information may prove to be incorrect. Events or circumstances may cause actual results to differ materially from those predicted, as a result of numerous known and unknown risks, uncertainties, and other factors, many of which are beyond the control of the Company, and which are described in the Company's public filings available under its profile at www.sedar.com. The reader is cautioned not to place undue reliance on any forward-looking information. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement. The forward-looking statements contained in this news release are made as of the date of this news release and the Company does not intend to update any of the included forward-looking statements except as required by Canadian securities laws.

LINDA ROSANIO
VSBLTY, INC
609-472-0877
LROSANIO@VSBLTY.NE

VSBLTY Groupe Technologies Corp. (CSE: VSBY) is a featured Tech / AI stock on Investorideas.com

Visit profile page

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Disclosure: VSBLTY is a paid PR, news and social media client on Investorideas.com as of March 1, 2019 https://www.investorideas.com/About/Disclaimer.asp

Contact management and IR of each company directly regarding specific questions.

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Get more tech stocks investor ideas- news, articles, podcasts and stock directories

About Investorideas.com

About Investorideas.com - Big Investing Ideas Investorideas.com is a platform for investing ideas. We publish breaking stock news, stock research, guest posts and create original top rated investing podcasts, plus sector tag articles featuring up and coming companies and industry leaders. Investor Idea’s original branded content includes the Crypto Corner Podcast , Play by Play Sports Podcast , Cannabis News and Stocks on the Move Podcast , Cleantech and Climate Change Podcast, Exploring Mining Podcast , Betting on Gaming Stocks Podcast and the AI Eye Podcast. We also create free investor stock directories for AI and tech, biotech, cannabis, cleantech, crypto, defense, gaming, health and wellness, mining, oil and gas, sports and water. Public companies within the sectors we cover can use our news publishing and content creation services to help tell their story to interested investors. Public companies within the sectors we cover use our news and content services to tell their story to interested investors. Paid for content is disclosed.

Discclaimer /disclosure

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

The AI Eye- Watching stock news, deal tracker and advancements in artificial intelligence is an original content brand of Investorideas.com

Investorideas.com breaking new for AI and tech stocks

Monday, July 22, 2019

The #AIEye: Microsoft (Nasdaq: $MSFT) Partners with OpenAI, Amazon (Nasdaq: $AMZN) Announces Two New #Robotics Fulfillment Centres and CEVA (Nasdaq: $CEVA) Acquires Hillcrest Labs

Friday, July 19, 2019

The #AIEye: BMW Joins Tencent (OTC: $TCEHY) to Launch Computing Centre in China for Self-Driving Cars and VMware (NYSE: $VMW) Acquires Startup Bitfusion

Investor Ideas Adds Recent IPO’s in #Biotech (NASDAQ: $PSNL) (NASDAQ: $STOK), #Tech (NASDAQ: $SONM) and #Defense (NYSE: $PSN)

AI News: VSBLTY (CSE: $VSBY.C) (OTC: $VSBGF) Announces Closing of Convertible Debenture Offering